23:42:23 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-08-29 Bokslutskommuniké 2025
2025-05-09 Kvartalsrapport 2025-Q3
2025-02-07 Kvartalsrapport 2025-Q2
2024-11-04 X-dag ordinarie utdelning VSD B 0.00 SEK
2024-11-01 Årsstämma 2025
2024-10-28 Kvartalsrapport 2025-Q1
2024-08-30 Bokslutskommuniké 2024
2024-04-19 Kvartalsrapport 2024-Q3
2024-04-12 Extra Bolagsstämma 2024
2024-02-09 Kvartalsrapport 2024-Q2
2023-10-27 Kvartalsrapport 2024-Q1
2023-09-25 X-dag ordinarie utdelning VSD B 0.00 SEK
2023-09-22 Årsstämma 2024
2023-08-31 Bokslutskommuniké 2023
2023-05-04 Kvartalsrapport 2023-Q3
2023-02-09 Kvartalsrapport 2023-Q2
2022-10-27 Kvartalsrapport 2023-Q1
2022-10-07 X-dag ordinarie utdelning VSD B 0.00 SEK
2022-10-06 Årsstämma 2023
2022-08-30 Bokslutskommuniké 2022
2022-07-05 Extra Bolagsstämma 2022
2022-05-04 Kvartalsrapport 2022-Q3
2022-02-11 Kvartalsrapport 2022-Q2
2021-10-22 Kvartalsrapport 2022-Q1
2021-10-06 X-dag ordinarie utdelning VSD B 0.00 SEK
2021-10-05 Årsstämma 2022
2021-08-30 Bokslutskommuniké 2021
2021-05-12 Kvartalsrapport 2021-Q3
2021-02-12 Kvartalsrapport 2021-Q2
2020-11-12 Kvartalsrapport 2021-Q1
2020-10-08 X-dag ordinarie utdelning VSD B 0.00 SEK
2020-10-07 Årsstämma 2021
2020-08-31 Bokslutskommuniké 2020
2020-05-15 Kvartalsrapport 2020-Q3
2020-05-04 Extra Bolagsstämma 2020
2020-02-14 Kvartalsrapport 2020-Q2
2019-11-01 Kvartalsrapport 2020-Q1
2019-10-10 X-dag ordinarie utdelning VSD B 0.00 SEK
2019-10-09 Årsstämma 2020
2019-08-30 Bokslutskommuniké 2019
2019-05-16 Kvartalsrapport 2019-Q3
2019-02-14 Kvartalsrapport 2019-Q2
2018-10-30 Kvartalsrapport 2019-Q1
2018-10-17 X-dag ordinarie utdelning VSD B 0.00 SEK
2018-10-16 Årsstämma 2019
2018-08-31 Bokslutskommuniké 2018
2018-05-16 Kvartalsrapport 2018-Q3
2018-02-14 Kvartalsrapport 2018-Q2
2017-10-30 Kvartalsrapport 2018-Q1
2017-10-02 X-dag ordinarie utdelning VSD B 0.00 SEK
2017-09-29 Årsstämma 2018
2017-08-30 Bokslutskommuniké 2017
2017-05-22 Kvartalsrapport 2017-Q3
2017-02-20 Kvartalsrapport 2017-Q2
2017-01-25 Extra Bolagsstämma 2017
2016-11-07 Kvartalsrapport 2017-Q1
2016-08-29 X-dag ordinarie utdelning VSD B 0.00 SEK
2016-08-26 Bokslutskommuniké 2016
2016-05-26 Kvartalsrapport 2016-Q3
2016-02-25 Kvartalsrapport 2016-Q2
2015-11-26 Kvartalsrapport 2016-Q1
2015-08-27 Bokslutskommuniké 2015

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Vibrosense Dynamics är verksamt inom medicinteknik. Bolaget utvecklar produkter och tjänster för diagnostikstöd vid nervskador i händer och fötter. Produkterna mäter och kvantifierar förmågan att känna vibrationer i huden, och används av vårdgivare för att kunna anpassa behandlingen eller sätta in förebyggande åtgärder vid potentiella nervskador. Bolagets kunder består huvudsakligen av diabetesmottagningar, sjukhus, vårdcentraler och forskningsinstitut.
2019-08-19 08:00:00

A published study authored by researchers at the clinic of Occupational and Environmental Medicine at Sahlgrenska University Hospital provides strong support for VibroSense Dynamics' new method for screening of workers, exposed for hand- arm vibrations. The screening method, developed by VibroSense together with two companies in Occupational Health Care services in Sweden, means that an examination can be made in less than 10 minutes. The method will be important for VibroSense expansion in Germany, among others.

The study, published in the Journal of Occupational Medicine and Toxicology, concludes that there are minor differences in the tactile sensitivity between dominant and non-dominant hand. In the study, workers exposed for vibrations were examined with several different methods, including with the company's product VibroSense Meter. The study also concludes that it is sufficient to examine the dominant hand to make a diagnosis.

The study's conclusions are very well in line with the screening method that VibroSense Dynamics develops together with two companies within occupational health care i.e. Runstenen and Avonova. The new screening method takes 10 minutes to complete and the examination is made on two fingers on the dominant hand of the worker or alternatively on the hand having any symptom.

The screening method will be released in the fall of 2019. Occupational Health Care and clinics of Occupational and Environmental Medicine will then get an effective tool for early identification of people at risk of developing a vibrational injury, which in turn will make it possible to avoid permanent damages by means of preventive measures.

VibroSense new method is based on clinical data from 2,750 unique individuals collected during 11 years from workers in the motor and construction industry. A total of 18,284 fingers have been examined. The corporate health Runstenen's clinical data is unique and the largest of its kind in the world, which has provided an invaluable basis for designing VibroSense new screening method.

About vibration injuries
The use of hand-held vibrating tools has been at a constant level for 10 years, causing a variety of damage to nerves, blood vessels, joints and muscles and white fingers. The injuries often cause lifelong suffering for the injured person. Affected occupational groups are, for example, people working in workshops, automotive, construction industry and dental care.

According to the Swedish Work Environment Authority, 400,000 workers in Sweden are exposed daily to vibrations from hand-held vibrating tools more than two hours a day.

The EU Directive 2002/44 / EC stipulates that all workers in the EU who are exposed above a certain exposure dose shall be offered regular health controls on fingers, hands and arms. Within the EU, it is estimated that over 25 million workers are exposed to potentially hazardous hand-arm vibrations on a daily basis. Germany and Benelux have stricter requirements than those stipulated in the EU Directive. 

Contact
Toni Speidel, VD VibroSense Dynamics AB,
Phone: +46 40 88 026
E-mail: info@vibrosense.com
www.vibrosense.com

About VibroSense Dynamics AB (publ)
VibroSense Dynamics AB (public) sells and develops efficient systems to support early detection and diagnosis of sensory neuropathy, i.e. disease of large nerve fibres and nerve trunks in e.g. legs and arms. Our vision is that the VibroSense Meter shall be the golden standard instrument for neurological examinations to assess sensory neuropathy and help to improve life conditions for patients having a risk of getting nerve injuries.